InterCure Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Public

  • Employees
  • 320

Employees

  • Stock Symbol
  • INCR

Stock Symbol

  • Investments
  • 9

  • Share Price
  • $1.52
  • (As of Friday Closing)

InterCure General Information

Description

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Contact Information

Website
www.canndoc.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Number 85 Medinat Hayehudim
  • Herzliya
  • Israel
+972
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Cultivation
Pharmaceuticals
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • Number 85 Medinat Hayehudim
  • Herzliya
  • Israel
+972

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InterCure Stock Performance

As of 20-Jun-2025, InterCure’s stock price is $1.52. Its current market cap is $82.9M with 54.5M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.52 $1.50 $1.17 - $2.62 $82.9M 54.5M 12.6K -$0.40

InterCure Financials Summary

As of 31-Dec-2024, InterCure has a trailing 12-month revenue of $64M.

In Thousands,
USD
TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 107,853 107,853 80,132 158,062
Revenue 64,050 64,050 95,967 115,568
EBITDA (14,483) (14,483) (7,902) 20,631
Net Income (18,180) (18,180) (16,723) 13,326
Total Assets 208,763 208,763 207,205 271,852
Total Debt 57,874 57,874 51,544 72,406
Public Fundamental Data provided by Morningstar, Inc. disclaimer

InterCure Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore InterCure‘s full profile, request access.

Request a free trial

InterCure Patents

InterCure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2574642-A1 Apparatus and method for breathing pattern determination using a non-contact microphone Inactive 23-Jul-2004
AU-2005264165-A1 Apparatus and method for breathing pattern determination using a non-contact microphone Inactive 23-Jul-2004
EP-1804649-A2 Apparatus and method for breathing pattern determination using a non-contact microphone Inactive 23-Jul-2004
EP-1804649-A4 Apparatus and method for breathing pattern determination using a non-contact microphone Inactive 23-Jul-2004
AU-2003286409-A1 Apparatus and method for beneficial modification of biorhythmic activity Active 13-Dec-2002 A61B5/486
To view InterCure’s complete patent history, request access »

InterCure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InterCure Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore InterCure‘s full profile, request access.

Request a free trial

InterCure Investments & Acquisitions (9)

InterCure’s most recent deal was a Merger/Acquisition with Leon Pharm for . The deal was made on 01-Jun-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Leon Pharm 01-Jun-2024 Merger/Acquisition Pharmaceuticals
Cannomed (2 Medical Cannabis Dispensing Pharmacies and Patient Support Center) 02-Sep-2021 Corporate Asset Purchase Therapeutic Devices
Pharmazone (Raanana) 18-May-2021 Merger/Acquisition Distributors (Healthcare)
Subversive Acquisition 23-Apr-2021 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
Here World 28-Jul-2020 Merger/Acquisition Other Healthcare Services
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

InterCure Exits (1)

InterCure’s most recent exit was on 17-Feb-2015 from Regenera Pharma. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Regenera Pharma 17-Feb-2015 Completed
  • 2 buyers
To view InterCure’s complete exits history, request access »

InterCure Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Leon Pharm Tel Aviv, Israel 1988

InterCure FAQs

  • When was InterCure founded?

    InterCure was founded in 1994.

  • Where is InterCure headquartered?

    InterCure is headquartered in Herzliya, Israel.

  • What is the size of InterCure?

    InterCure has 320 total employees.

  • What industry is InterCure in?

    InterCure’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is InterCure a private or public company?

    InterCure is a Public company.

  • What is InterCure’s stock symbol?

    The ticker symbol for InterCure is INCR.

  • What is the current stock price of InterCure?

    As of 20-Jun-2025 the stock price of InterCure is $1.52.

  • What is the current market cap of InterCure?

    The current market capitalization of InterCure is $82.9M.

  • What is InterCure’s current revenue?

    The trailing twelve month revenue for InterCure is $64M.

  • What is InterCure’s annual earnings per share (EPS)?

    InterCure’s EPS for 12 months was -$0.40.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »